Archive for July, 2012

AHRQ Publishes RFI on HIT Enabled Quality Measurement

July 24, 2012 Leave a comment

On July 20, the Agency for Healthcare Research and Quality (AHRQ) published in the Federal Register a Request for Information (RFI) on current successful strategies and challenges regarding quality measurement enabled by HIT.  The public comment period closes on August 20.

The RFI lists fifteen questions related to e-measure generation:  Read more…

Categories: EHR, meaningful use, research

Recap of Recent Federal HIT Policy Developments

July 16, 2012 Leave a comment

July 10 – The U.S. Food and Drug Administration published a proposed rule regarding the unique device identifier (UDI) system.  Policymakers believe a well-planned UDI system has the potential to improve the quality of information in medical device adverse events reports.  The public comment period for the proposed rule closes on November 7.

July 10 – The HHS Office of the National Coordinator for HIT (ONC) HIT Policy Committee held its monthly business meeting to discuss the latest Medicare/Medicaid EHR Incentive Program statistics, Regional Extension Center identified “meaningful use” barriers, and agency activities.  Of note, Dr. Farzad Mostashari, the National Coordinator for HIT, announced that Joshua Seidman, ONC Director of Meaningful Use, is leaving the agency to pursue other opportunities.

July 11 – ONC hosted a public hearing on “trusted identity of providers in cyberspace.”  The intended purpose of the meeting was to discuss Privacy and Security Tiger Team efforts and other issues pertaining to identity proofing and authentication.  Speakers included representatives from various federal government agencies, HIE networks, and private companies that are active in this area.

July 16 – The National Academy of Sciences press published a report from the February 2012 workshop on “Informatics Needs and Challenges in Cancer Research.”  The American College of Radiology Imaging Network participated in the workshop.

July 9 – The National Institute of Standards and Technology (NIST) published a call for nominations for various federal advisory committees administered by the agency.

President Signs FDA Safety and Innovation Act

Earlier today, President Barack Obama signed into law S. 3187, the Food and Drug Administration (FDA) Safety and Innovation Act. The primary purpose of the legislation is to renew and enhance the user-fee programs for drugs and medical devices.

Among many other things, the legislation requires the FDA, Office of the National Coordinator for HIT (ONC), and the Federal Communications Commission (FCC) to develop a report detailing a “proposed strategy and recommendations on an appropriate, risk-based regulatory framework pertaining to health information technology, including mobile medical applications, that promotes innovation, protects patient safety, and avoids regulatory duplication” within 18 months of enactment.  The legislation also authorizes the Secretary of HHS to establish a geographically diverse and balanced working group to inform the process.

An HHS press release about the legislation is now available.

Categories: FDA, radiation safety, research
%d bloggers like this: